Synthesis and biological activities of indolizine derivatives as alpha-7 nAChR agonists

Eur J Med Chem. 2016 Jun 10:115:94-108. doi: 10.1016/j.ejmech.2016.03.016. Epub 2016 Mar 8.

Abstract

Human α7 nicotinic acetylcholine receptor (nAChR) is a promising therapeutic target for the treatment of schizophrenia accompanied with cognitive impairment. Herein, we report the synthesis and agonistic activities of a series of indolizine derivatives targeting to α7 nAChR. The results show that all synthesized compounds have affinity to α7 nAChR and some give strong agonistic activity, particularly most active agonists show higher potency than control EVP-6124. The docking and structure-activity relationship studies provide insights to develop more potent novel α7 nAChR agonists.

Keywords: Agonists; Indolizine; SAR; Schizophrenia; α7 nAChR.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Dose-Response Relationship, Drug
  • Humans
  • Indolizines / chemical synthesis*
  • Indolizines / chemistry
  • Indolizines / pharmacology*
  • Molecular Docking Simulation
  • Molecular Structure
  • Structure-Activity Relationship
  • alpha7 Nicotinic Acetylcholine Receptor / agonists*

Substances

  • Indolizines
  • alpha7 Nicotinic Acetylcholine Receptor
  • indolizine